Publication title

The clinical impact of Lumacaftor-Ivacaftor on structural lung disease and lung function in children aged 6–11 with cystic fibrosis in a real-world setting

Date

Aug 2023

Source

Respiratory Research

View publication

Want to know more?

Share this content: